Concepedia

C Gasink

CG

Statistics

Publications

7

Citations

404

H-Index

7

Active since

2016

Affiliations

Janssen (United States)(Current)

Icahn School of Medicine at Mount Sinai

University of California San Diego

Western University

Janssen Scientific Affairs (United States)

C Gasink is an author at Janssen (United States) specializing in medicine, gastroenterology, and immunology.

Top concepts

Publications per year

2016–2023

7

Publications

7

Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy

William J. Sandborn, P. Rutgeerts, C Gasink et al. · Alimentary Pharmacology & Therapeutics · 2018 · 178 citations · Full text

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

Subrata Ghosh, Lianne S. Gensler, Zijiang Yang et al. · Drug Safety · 2019 · 114 citations · Full text

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

Amanda M. Johnson, Maria Barsky, Waseem Ahmed et al. · The American Journal of Gastroenterology · 2022 · 63 citations

OP010 Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years

William J. Sandborn, P. Rutgeerts, C Gasink et al. · Journal of Crohn s and Colitis · 2017 · 13 citations · Full text

P495 Perianal fistula closure in patients receiving ustekinumab: Results from the SEAVUE and STARDUST trials

Laurent Peyrin‐Biroulet, Remo Panaccione, C Gasink et al. · Journal of Crohn s and Colitis · 2022 · 13 citations · Full text

, , +10

Rows per page

1–5 of 7